• LIST OF TABLES AND FIGURES
• INTRODUCTION
• CAUSE OF THE DISEASE
• RISK FACTORS & PREVENTION
• DIAGNOSIS OF THE DISEASE
• VARIATION BY GEOGRAPHY/ETHNICITY
• DISEASE PROGNOSIS & CLINICAL COURSE
• STANDARDISATION OF UVEITIS NOMENCLATURE (SUN) WORKING GROUP GUIDELINES
• KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE
• METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS
• TOP-LINE PREVALENCE FOR UVEITIS
• FEATURES OF UVEITIS PATIENTS
• AETIOLOGY OF UVEITIS
• INFECTIOUS CAUSES OF UVEITIS
• AUTOIMMUNE CAUSES OF UVEITIS
• VISION LOSS IN UVEITIS
• COMORBID OPHTHALMIC CONDITIONS IN UVEITIS
• ABBREVIATIONS USED IN THE REPORT
• OTHER BLACK SWAN SERVICES & SOLUTIONS
• REPORTS & PUBLICATIONS
• ONLINE EPIDEMIOLOGY DATABASES
• ONLINE PHARMACEUTICAL PRICING DATABASE
• REFERENCES
• APPENDIX

LIST OF TABLES AND FIGURES
Table 1. Signs and symptoms of uveitis by the affected section of the eye
Table 2. The SUN working group descriptors of uveitis
Table 3. Prevalence of uveitis, total (000s)
Table 4. Prevalence of uveitis, males (000s)
Table 5. Prevalence of uveitis, females (000s)
Table 6. Patients with uveitis by anatomical site, total (000s)
Table 7. Patients with anterior uveitis by aetiology, total (000s)
Table 8. Patients with anterior uveitis by duration of attack, total (000s)
Table 9. Patients with intermediate uveitis by aetiology, total (000s)
Table 10. Patients with posterior uveitis by aetiology, total (000s)
Table 11. Patients with panuveitis by aetiology, total (000s)
Table 12. Patients with infectious uveitis by causal agent, total (000s)
Table 13. Patients with autoimmune uveitis by causal condition, total (000s)
Table 14. Uveitis patients with vision loss (acuity ?6/18), total (000s)
Table 15. Uveitis patients with vision loss (acuity ?6/18) by laterality, total (000s)
Table 16. Uveitis patients with vision loss (acuity ?6/18) by cause, total (000s)
Table 17. Uveitis patients with hypopyon, total (000s)
Table 18. Uveitis patients with ocular hypertension, total (000s)
Table 19. Uveitis patients with macular oedema, total (000s)
Table 20. Uveitis patients with epiretinal membranes, total (000s)
Table 21. Abbreviations and acronyms used in the report
Table 22. USA prevalence of uveitis by 5-yr age cohort, males (000s)
Table 23. USA prevalence of uveitis by 5-yr age cohort, females (000s)
Table 24. Canada prevalence of uveitis by 5-yr age cohort, males (000s)
Table 25. Canada prevalence of uveitis by 5-yr age cohort, females (000s)
Table 26. France prevalence of uveitis by 5-yr age cohort, males (000s)
Table 27. France prevalence of uveitis by 5-yr age cohort, females (000s)
Table 28. Germany prevalence of uveitis by 5-yr age cohort, males (000s)
Table 29. Germany prevalence of uveitis by 5-yr age cohort, females (000s)
Table 30. Italy prevalence of uveitis by 5-yr age cohort, males (000s)
Table 31. Italy prevalence of uveitis by 5-yr age cohort, females (000s)
Table 32. Spain prevalence of uveitis by 5-yr age cohort, males (000s)
Table 33. Spain prevalence of uveitis by 5-yr age cohort, females (000s)
Table 34. UK prevalence of uveitis by 5-yr age cohort, males (000s)
Table 35. UK prevalence of uveitis by 5-yr age cohort, females (000s)
Table 36. Poland prevalence of uveitis by 5-yr age cohort, males (000s)
Table 37. Poland prevalence of uveitis by 5-yr age cohort, females (000s)
Table 38. Netherlands prevalence of uveitis by 5-yr age cohort, males (000s)
Table 39. Netherlands prevalence of uveitis by 5-yr age cohort, females (000s)
Table 40. Turkey prevalence of uveitis by 5-yr age cohort, males (000s)
Table 41. Turkey prevalence of uveitis by 5-yr age cohort, females (000s)
Table 42. Japan prevalence of uveitis by 5-yr age cohort, males (000s)
Table 43. Japan prevalence of uveitis by 5-yr age cohort, females (000s)
Table 44. China prevalence of uveitis by 5-yr age cohort, males (000s)
Table 45. China prevalence of uveitis by 5-yr age cohort, females (000s)
Table 46. South Korea prevalence of uveitis by 5-yr age cohort, males (000s)
Table 47. South Korea prevalence of uveitis by 5-yr age cohort, females (000s)
Table 48. India prevalence of uveitis by 5-yr age cohort, males (000s)
Table 49. India prevalence of uveitis by 5-yr age cohort, females (000s)
Table 50. Australia prevalence of uveitis by 5-yr age cohort, males (000s)
Table 51. Australia prevalence of uveitis by 5-yr age cohort, females (000s)
Table 52. Brazil prevalence of uveitis by 5-yr age cohort, males (000s)
Table 53. Brazil prevalence of uveitis by 5-yr age cohort, females (000s)
Table 54. Mexico prevalence of uveitis by 5-yr age cohort, males (000s)
Table 55. Mexico prevalence of uveitis by 5-yr age cohort, females (000s)
Table 56. Argentina prevalence of uveitis by 5-yr age cohort, males (000s)
Table 57. Argentina prevalence of uveitis by 5-yr age cohort, females (000s)

• Figure 1. Colour representation of the eye sections affected by each anatomical category of uveitis: blue—anterior uveitis, green—intermediate uveitis, purple—posterior uveitis; panuveitis encompasses all three sections